AXIM Biotechnologies, Inc. (AXIM)

0,0137 +0,0015 (+11,84%) Börsenschluss: 03:11PM EDT

AXIM Biotechnologies, Inc.

6191 Cornerstone Court, East
Suite 114
San Diego, CA 92121
United States
858 923 4422
https://www.aximbiotech.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 6

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. John W. Huemoeller II	President, CEO & Director	420k	N/A	1955
Mr. Robert T. Malasek	CFO & Secretary	90k	N/A	1968
Ms. Catalina Valencia J.D.	Co-Founder & CEO of Sapphire Biotech, Inc.	187,5k	N/A	1949
Mr. Kurt Phinney	Chief Operating Officer	N/A	N/A	1973
Dr. Sergei A. Svarovsky M.B.A., Ph.D.	Chief Scientific Officer & Co-Founder of Sapphire Biotech, Inc.	N/A	N/A	N/A
Dr. Douglas Lake Ph.D.	Chief Clinical Officer of Sapphire Biotech, Inc.	N/A	N/A	N/A
Dr. Alim Seit-Nebi Ph.D.	CTO & Co-Founder of Sapphire Biotech, Inc.	N/A	N/A	N/A
Mr. Jeffrey A. Busby	Senior Vice President of Business Development	N/A	N/A	N/A
Dr. Joseph Tauber M.D.	Chief Medical Officer & Chairman of the Medical Advisory Board	N/A	N/A	1957
Dr. Maria J. Gonzalez Moa Ph.D.	Vice President of Product Development - Sapphire Biotech, Inc.	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

Corporate Governance

AXIM Biotechnologies, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.